about
Insulin upregulates betatrophin expression via PI3K/Akt pathwayInsulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer.Emerging regulation and function of betatrophinLigand-Binding Affinity at the Insulin Receptor Isoform-A and Subsequent IR-A Tyrosine Phosphorylation Kinetics are Important Determinants of Mitogenic Biological Outcomes.Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence.Evolution of phage display technology: from discovery to application.Disruption of insulin receptor function inhibits proliferation in endocrine-resistant breast cancer cellsDeciphering Brain Insulin Receptor and Insulin-Like Growth Factor 1 Receptor Signalling.Pursuit of a perfect insulin.Glycosides from Stevia rebaudiana Bertoni Possess Insulin-Mimetic and Antioxidant Activities in Rat Cardiac FibroblastsAn ultra-stable single-chain insulin analog resists thermal inactivation and exhibits biological signaling duration equivalent to the native protein.Insulin-Like Growth Factor (IGF) Binding Protein-2, Independently of IGF-1, Induces GLUT-4 Translocation and Glucose Uptake in 3T3-L1 Adipocytes.Steady-State Differential Dose Response in Biological Systems.Thymosin β4 significantly reduces the signs of dryness in a murine controlled adverse environment model of experimental dry eye.Rutin potentiates insulin receptor kinase to enhance insulin-dependent glucose transporter 4 translocation.
P2860
Q33912235-25269B99-0231-48C6-9CD9-39A932E75490Q34391968-10D2004F-BE7D-44B4-BD85-BE394C22172EQ34835947-DC04D17B-B5FB-44C8-BD88-0D8051225644Q35824181-0EC319A2-47C5-40FC-8FA7-969CF6E11017Q35937961-4FD6B4CB-44E9-454F-BF8F-F46E5D4EDC9EQ36183954-53CA8F21-4341-419F-A00F-C4F844D773DEQ37171068-4E3FB4B5-42D0-4673-9303-C31885B98C21Q37456221-BF0A47D8-85D0-4F64-B038-726E95067FE3Q38778988-1957D804-063C-4898-916D-CCD4D093D6E4Q41694448-EB363125-E30E-4FBA-A76C-91236CBBA5E8Q47371507-FC078160-21FC-47B0-A314-A89DD4360368Q49480728-07FEB2E9-E2A9-4147-A5C6-09FF5F738C57Q50134389-FD2F3EA2-7190-467E-86C9-1A599EE91306Q53459932-1B8BD211-EF2D-41C3-AEF8-09F2E8F8DC37Q54364787-5DD64DFB-6CCF-4D84-8FC7-A586CE6F67A8
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Agonism and antagonism at the insulin receptor.
@ast
Agonism and antagonism at the insulin receptor.
@en
Agonism and antagonism at the insulin receptor.
@nl
type
label
Agonism and antagonism at the insulin receptor.
@ast
Agonism and antagonism at the insulin receptor.
@en
Agonism and antagonism at the insulin receptor.
@nl
prefLabel
Agonism and antagonism at the insulin receptor.
@ast
Agonism and antagonism at the insulin receptor.
@en
Agonism and antagonism at the insulin receptor.
@nl
P2093
P2860
P1433
P1476
Agonism and antagonism at the insulin receptor.
@en
P2093
Bo Falck Hansen
Kirsten Vestergaard
Lauge Schäffer
Louise Knudsen
Martin B Oleksiewicz
Pia Jensen
Thomas Åskov Pedersen
Vladislav V Kiselyov
P2860
P304
P356
10.1371/JOURNAL.PONE.0051972
P407
P577
2012-12-27T00:00:00Z